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Abstract 
Feed and feed ingredients have been shown to be potential vectors of porcine epidemic diarrhea virus 
(PEDV). Potential strategies to mitigate the risk of disease transmission via feed and feed ingredients 
would be valuable to the swine and feed milling industries. Therefore, the objective of this experiment was 
to determine the impact of VevoVitall (5,000 ppm; DSM Nutritional Products Inc., Parsipanny, NJ), CRINA 
(200 ppm; DSM Nutritional Products Inc., Parsipanny, NJ), and a combination of both products 
(COMBINATION; 5,000 ppm VevoVitall and 200 ppm CRINA) as feed additives with potential to mitigate 
the risk of PEDV, in swine gestation diet (FEED) and spraydried porcine plasma (SDPP) as determined by 
real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analyzed at seven 
sampling days post laboratory inoculation (d 0, 1, 3, 7, 14, 21, and 42) and bioassay. There was a 
marginally significant treatment × feed matrix × day interaction (P = 0.082), in which the cycle threshold 
(Ct) value increased over time in the diet when treated with the COMBINATION, whereas, there was no 
increase over time observed in SDPP. There was a highly significant (P < 0.001) feed matrix × day 
interaction in which the Ct increased over time in FEED, whereas, there was very little increase over time 
observed in SDPP. Additionally, there was a marginally significant treatment × feed matrix interaction (P = 
0.079). Overall, the COMBINATION was most effective at reducing the quantity of genetic material as 
detected by qRT-PCR (P < 0.001). Virus shedding was observed in the d 7 post-inoculation SDPP 
COMBINATION treatment, as well as d 0 FEED COMBINATION treatment. No other treatment bioassay 
room had detectable RNA shed and detected in fecal swabs or cecal contents (d 1, 3, 7, 14, and 21 post-
laboratory inoculation FEED, COMBINATION). 
In summary, the combination of CRINA and VevoVitall enhanced degradation of PEDV RNA in swine feed, 
but had no impact on RNA degradation in SDPP. Furthermore, both untreated feed and feed treated with 
the combination of CRINA and VevoVitall caused infection at d 0 post-laboratory inoculation; however, 
neither set of samples was infective at d 1 post-laboratory inoculation. 
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Evaluating the Impact of VevoVitall and/or  
CRINA as Potential Porcine Epidemic 
Diarrhea Virus Mitigation Strategies as 
Determined by Polymerase Chain Reaction 
Analysis and Bioassay1,2
J.T. Gebhardt, J.C. Woodworth, C.K. Jones, M.D. Tokach, J.M. DeRouchey, 
R.D. Goodband, R.A. Cochrane, C.R. Stark,3 J.R. Bergstrom,4 P.C. Gauger,5 
J. Bai,6 Q. Chen,5 J. Zhang,5 R.G. Main,5 and S.S. Dritz6 
 
Summary
Feed and feed ingredients have been shown to be potential vectors of porcine epidemic 
diarrhea virus (PEDV). Potential strategies to mitigate the risk of disease transmission 
via feed and feed ingredients would be valuable to the swine and feed milling industries. 
Therefore, the objective of this experiment was to determine the impact of VevoVitall 
(5,000 ppm; DSM Nutritional Products Inc., Parsipanny, NJ), CRINA (200 ppm; 
DSM Nutritional Products Inc., Parsipanny, NJ), and a combination of both products 
(COMBINATION; 5,000 ppm VevoVitall and 200 ppm CRINA) as feed additives 
with potential to mitigate the risk of PEDV, in swine gestation diet (FEED) and spray-
dried porcine plasma (SDPP) as determined by real time quantitative reverse tran-
scriptase polymerase chain reaction (qRT-PCR) analyzed at seven sampling days post 
laboratory inoculation (d 0, 1, 3, 7, 14, 21, and 42) and bioassay. There was a marginally 
significant treatment × feed matrix × day interaction (P = 0.082), in which the cycle 
threshold (Ct) value increased over time in the diet when treated with the COMBI-
NATION, whereas, there was no increase over time observed in SDPP. There was a 
highly significant (P < 0.001) feed matrix × day interaction in which the Ct increased 
over time in FEED, whereas, there was very little increase over time observed in SDPP. 
1  Appreciation is expressed to Dr. Charles Farenholtz (Phibro Animal Health, Teaneck, NJ) for techni-
cal support and use of facilities and equipment, Dr. Dick Hesse and Joe Anderson for technical support 
and laboratory use, Elizabeth Poulsen and Rusty Ransbrough for technical support and laboratory use, 
Dr. Joe Crenshaw (APC Functional Proteins, Ankeny, IA), as well as Marut Saensukjaroenphon and 
Mary Muckey for technical support.
2  Appreciation is expressed to DSM Nutritional Products, Inc. (Parsippany, NJ) for project funding.
3  Department of Grain Science and Industry, Kansas State University.
4  DSM Nutritional Products, Inc., Parsippany, NJ.
5  Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine,  
Iowa State University, Ames, IA.
6  Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine,  
Kansas State University.
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Additionally, there was a marginally significant treatment × feed matrix interaction (P 
= 0.079). Overall, the COMBINATION was most effective at reducing the quantity 
of genetic material as detected by qRT-PCR (P < 0.001). Virus shedding was observed 
in the d 7 post-inoculation SDPP COMBINATION treatment, as well as d 0 FEED 
COMBINATION treatment. No other treatment bioassay room had detectable RNA 
shed and detected in fecal swabs or cecal contents (d 1, 3, 7, 14, and 21 post-laboratory 
inoculation FEED, COMBINATION). 
In summary, the combination of CRINA and VevoVitall enhanced degradation 
of PEDV RNA in swine feed, but had no impact on RNA degradation in SDPP. 
Furthermore, both untreated feed and feed treated with the combination of CRINA 
and VevoVitall caused infection at d 0 post-laboratory inoculation; however, neither set 
of samples was infective at d 1 post-laboratory inoculation.
Key words: feed additive, feed matrix, PEDV, swine
Introduction
Feed and feed ingredients have been shown to be potential vectors of Porcine Epidemic 
Diarrhea virus (PEDV).7,8 Therefore, potential strategies to mitigate the risk of disease 
transmission via feed and feed ingredients would be valuable to the swine and feed 
manufacturing industries. Research has been conducted assessing potential mitigation 
techniques, such as the use of certain feed additives or thermal processing during pellet-
ing of diets. During the pelleting of complete swine diets, previous research has shown 
that a pelleting conditioner temperature of 130°F was effective at minimizing the risk of 
PEDV transfer.9 The application of certain feed additives, including medium chain fatty 
acids, essential oils, organic acids, and formaldehyde, has been effective at degrading 
PEDV genetic material in complete feed and feed ingredients as quantified by quanti-
tative real-time polymerase chain reaction (qRT-PCR), but lack of infectivity has not 
been verified via bioassay.10 
CRINA and VevoVitall are two commercially available products sold by DSM Nutri-
tional Products (Parsipanny, NJ). CRINA is a combination of essential oils designed to 
stimulate gut health in swine, and VevoVitall is a 99.9% benzoic acid product designed 
7  Dee, S., T. Clement, A. Schelkopf, J. Nerem, D. Knudsen, J. Christopher-Hennings, and E. Nelson. 
2014. An evaluation of contaminated complete feed as a vehicle for porcine epidemic diarrhea virus 
infection of naive pigs following consumption via natural feeding behavior: Proof of concept. BMC 
Veterinary Research. 10(176).
8  Pillatzki, A. E., P. C. Gauger, D. M. Madson, E. R. Burrough, JianQiang Zhang, Q. Chen, D. R. Mag-
stadt, P. H. E. Arruda, G. W. Stevenson, and K. J. J. Yoon. 2015. Experimental inoculation of neonatal 
piglets with feed naturally contaminated with porcine epidemic diarrhea virus. Journal of Swine Health 
and Production. 23(6): 317-320.
9 Cochrane, R. A., S. S. Dritz, J. C. Woodworth, A. R. Huss, C. R. Stark, R. A. Hesse, JianQiang Zhang, 
M. D. Tokach, J. Bai, and C. K. Jones. 2015. Evaluating chemical mitigation of Porcine Epidemic Diar-
rhea Virus (PEDV) in swine feed and ingredients. Kansas State University Swine Day 2015. Kansas 
Agricultural Experiment Station Research Reports. Vol. 1: Iss. 7.
10 Cochrane, R. A., L. L. Schumacher, S. S. Dritz, J. C. Woodworth, A. R. Huss, C. R. Stark, J. M. 
DeRouchey, M. D. Tokach, R. D. Goodband, J. Bai, Q. Chen, JianQiang Zhang, P. C. Gauger, R. G. 
Main, and C. K. Jones. 2015. Effect of thermal mitigation on Porcine Epidemic Diarrhea Virus (PEDV)-
contaminated feed. Kansas State University Swine Day 2015. Kansas Agricultural Experiment Station 
Research Reports. Vol. 1: Iss. 7.
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to reduce activity of microorganisms in feed, including fungi, yeasts and certain bacteria, 
such as E. coli and Salmonella.11 However, neither CRINA nor VevoVitall have been 
tested as potential PEDV mitigants. Therefore, the objective of this experiment was to 
determine the impact of VevoVitall and CRINA as feed additives with the potential to 
mitigate PEDV contamination of feed and spray-dried porcine plasma as determined by 




Treatment structure was designed in a 2 × 2 × 2 factorial arrangement with two feed 
matrices (FEED and SDPP) and feed additive treatment factors including VevoVitall 
(5,000 ppm; DSM Nutritional Products Inc., Parsippany, NJ) and CRINA (200 ppm; 
DSM Nutritional Products Inc., Parsippany, NJ), and combination of both products 
(COMBINATION; 5,000 ppm VevoVitall and 200 ppm CRINA). The swine diet 
(Table 1) used in this experiment was manufactured at the Kansas State University 
O.H. Kruse Feed Technology Innovation Center in Manhattan, KS, and was verified to 
be devoid of PEDV and porcine delta-coronavirus (PDCoV) ribonucleic acid (RNA) 
as determined via qRT-PCR prior to initiation of the experiment. Spray-dried porcine 
plasma (APC Functional Proteins, Ankeny, IA) was also verified to be free of both 
PEDV and delta-coronavirus RNA prior to use as verified by qRT-PCR. 
Feed Additive Treatment
Prior to treatment of feed matrices with feed additive treatments, a 25.0 g sample 
of each feed matrix was collected and placed in its appropriate bottle. These samples 
received no virus, and were the positive control samples reserved for the bioassay por-
tion of the experiment. A benchtop paddle mixer was used as previously described12 for 
mixing dry products with FEED. Mixing time was 3 min, as was previously verified with 
a CV of < 10% using a chloride mixer efficiency procedure (Quantab; Hach Co., Love-
land, CO). A V-mixer (Cross-Flow Blender; Patterson-Kelley Co., East Stroudsburg, 
PA) was used to mix feed additive treatments with SDPP. A mixer efficiency test was 
performed using spray-dried bovine plasma, and resulted in a uniform mix with a mix 
time of 7.0 min (MicroTracer-F; Microtracers Inc., San Francisco, CA). 
Following the mixing of feed matrix and corresponding feed additive treatment, 22.5 g 
of chemically treated feed matrix was sampled and placed in the appropriate bottle (250 
mL Nalgene square wide-mouth HDPE; Thermo Fisher Scientific, Waltham, MA) to 
be inoculated with PEDV and analyzed on seven sampling days post laboratory inocula-
tion (d 0, 1, 3, 7, 14, 21, and 42), with 3 replications of each sampling day/feed additive 
treatment combination. This process was repeated for each feed matrix × feed additive 
treatment combination. Both the paddle mixer and V-blender were cleaned between 
feed additive treatments initially by high-pressure air, then a flush step was performed 
11 DSM Nutritional Products, Inc., Parsippany, NJ; http://www.dsm.com/markets/anh/en_US/prod-
ucts/products-eubiotics/products-eubiotics-vevovitall.html, Accessed 1/13/2016.
12  Schumacher, L. L., J. C. Woodworth, C. R. Stark, C. K. Jones, R. A. Hesse, R. G. Main, Jianqiang 
Zhang, P. C. Gauger, S. S. Dritz, and M. D. Tokach. 2015. Determining the minimum infectious dose 
of Porcine Epidemic Diarrhea Virus (PEDV) in a feed matrix. Kansas State University Swine Day 2015. 
Kansas Agricultural Experiment Station Research Reports. Vol. 1: Iss. 7.
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with either untreated FEED or SDPP for the paddle mixer and V-blender, respectively, 
followed by a final cleaning with high-pressure air. 
   
Inoculation
Inoculation was carried out at the Kansas State University College of Veterinary 
Medicine Virology Laboratory. The viral inoculum was cell culture derived USA/
IN/2013/19338, passage 8 and had an initial concentration of 106 TCID50/mL. Fifty 
mL of concentrated inoculum was mixed with 450 mL of tissue culture media, resulting 
in a diluted inoculum concentration of 105 TCID50/mL. Inoculation occurred by pipet-
ting 2.5 mL of diluted viral inoculum into each bottle containing 22.5 g feed matrix, re-
sulting in an inoculated feed matrix with a viral concentration of 104 TCID50/g of feed 
matrix. Following addition of the viral inoculum to each bottle, the bottles were lightly 
shaken in a circular pattern for approximately five seconds, after which each bottle was 
vigorously hand shaken for approximately 10 sec to mix the virus evenly within each 
bottle.  
Real-time PCR analysis
Separate bottles were analyzed on d 0, 1, 3, 7, 14, 21, and 42 post-laboratory inocula-
tion. On each day of analysis, 100 mL phosphate buffered saline (PBS; pH 7.4 1X, Life 
Technologies, Grand Island, NY) was added to each bottle predetermined for analysis 
on that day. Bottles were shaken for approximately 10 sec, at which point they were 
allowed to settle overnight at 39.2°F. The following day, supernatant was pulled and ali-
quoted for further analysis. A total of 4 aliquots from each sample bottle were collected 
and stored at -4°F until the conclusion of the trial, at which point qRT-PCR analysis 
was performed on one aliquot per sample bottle and the remaining three samples per 
bottle were stored at -112°F until transported to Iowa State University for the initia-
tion of the bioassay portion of the experiment.
After collection of d 42 post-laboratory inoculation aliquots, qRT-PCR was conducted 
on designated preserved aliquots at Kansas State University Veterinary Diagnostic 
Laboratory Molecular Diagnostics Lab as previously described.12 Fifty microliters (µL) 
of supernatant from each sample was loaded into a deep well plate and extracted using 
a Kingfisher 96 magnetic particle processor (Fisher Scientific, Pittsburg, PA) and the 
MagMAX-96 Viral RNA Isolation kit (Life Technologies, Grand Island, NY) accord-
ing to the manufacturer’s instructions with one modification, reducing the final elution 
volume to 60 µL. One negative extraction control consisting of all reagents except the 
sample was included in each extraction. The extracted RNA was frozen at -4°F until 
assayed by qRT-PCR. Analyzed values represent cycle threshold (Ct) at which virus 
was detected. A greater Ct value indicates more cycles must proceed until viral genetic 
material is detected, thus lower quantities of genetic material are present in the original 
sample.




A bioassay was performed using selected treatment × time combinations at Iowa State 
University Veterinary Diagnostic Laboratory to determine the viral infectivity charac-
teristics following protocols previously described by Pillatzki et al., 201513 and Thomas 
et al., 2015.14  
The experimental protocol for the pig bioassay portion of the experiment was reviewed 
and approved by the Iowa State University Institutional Animal Care and Use Com-
mittee. Forty-eight crossbred, 10 d-old pigs of mixed sex were sourced from a single 
commercial, crossbred farrow-to-wean herd with no prior exposure to PEDV. Upon 
arrival, piglets were ear tagged, weighed, and administered a dose of cefitiofur (Excede, 
Zoetis, Florham Park, NJ). Also upon arrival, fecal swabs were obtained and confirmed 
negative for PEDV, porcine delta coronavirus (PDCoV), and transmissible gastro-
enteritis virus (TGEV) using a qRT-PCR assay. To further confirm PEDV negative 
status, serum was collected and confirmed negative for PEDV antibody by an indirect 
fluorescent antibody (IFA) assay and TGEV antibody by enzyme-linked immuno-
sorbent assay (ELISA) conducted at the Iowa State University Veterinary Diagnostic 
Laboratory (ISU-VDL). Pigs were allowed 2 d of adjustment to the new pens before the 
bioassay began.
Briefly, pigs from each experimental treatment were housed in separate rooms with 
independent ventilation systems. Rooms had solid flooring that was minimally rinsed 
to reduce risk of PEDV aerosolization. Pigs were fed liquid milk replacer twice daily and 
offered a commercial pelleted swine diet ad libitum with free access to water. Each pig 
was administered 10 mL of the PBS supernatant treatment by orogastric gavage using 
an 8-gauge French catheter 0 d post-bioassay inoculation (dpi).
Rectal swabs were collected on d -2, 0, 2, 4, and 6 dpi from all piglets and tested for 
PEDV RNA via qRT-PCR. Fresh small intestine, cecum, and colon were collected at 
necropsy at 7 dpi, along with an aliquot of cecal content. One section of formalin-fixed 
proximal, middle, and distal jejunum and ileum were collected for histopathology. 
Cecal content was evaluated for PEDV via qRT-PCR. Tissue was routinely processed 
and fixed in neutral buffered formalin, embedded, sectioned, and stained with 
hematoxylin and eosin stain. One section of proximal, middle, and distal jejunum; and 
three serial sections from the piece of ileum (for a total of six sections of intestine) were 
evaluated by a veterinary pathologist blind to the treatments. Morphology and IHC 
data were excluded from the current report.
13  Pillatzki, A. E., P. C. Gauger, D. M. Madson, E. R. Burrough, Zhang JianQiang, Q. Chen, D. R. Mag-
stadt, P. H. E. Arruda, G. W. Stevenson, and K. J. J. Yoon. 2015. Experimental inoculation of neonatal 
piglets with feed naturally contaminated with porcine epidemic diarrhea virus. Journal of Swine Health 
and Production. 23(6): 317-320.
14  Thomas, J. T., Qi Chen, P. C. Gauger, L. G. Gimenez-Lirola, Avanti Sinha, K. M. Harmon, D. M. 
Madson, E. R. Burrough, D. R. Magstadt, H. M. Salzbrenner, M. W. Welch, Yoon Kyoung-Jin, J. J. 
Zimmerman, and Zhang Jian Qiang. 2015. Effect of porcine epidemic diarrhea virus infectious doses on 
infection outcomes in naive conventional neonatal and weaned pigs. PLOS ONE. 10(10): e0139266.




Data were analyzed using PROC GLIMMIX (SAS Institute, Inc., Cary, NC) to deter-
mine the main effects of feed additive treatment, feed matrix, as well as day post-labo-
ratory inoculation and all associated interactions on PEDV Ct values with individual 
sample bottle as the experimental unit. Bottle within treatment was included in the 
model as the subject of the repeated measure of day after laboratory inoculation. Bottle 
was included in the statistical model as a random effect. Results for the response criteria 
were considered significant at P ≤ 0.05 and marginally significant from P > 0.05 to  
P ≤ 0.10.
Results and Discussion
Quantity of Detectable Viral RNA 
There was a marginally significant treatment × feed matrix × day interaction 
(P = 0.082, Table 2) in which the combination of CRINA and VevoVitall resulted in 
a reduction of quantifiable RNA on d 21 and 42 at a greater rate in feed than in the 
SDPP matrix. There was a significant (P < 0.001, Table 2) feed matrix × day interaction 
in which the Ct value increased over time in gestation diet, whereas there was very little 
increase over time observed in SDPP. Additionally, there was a marginally significant 
treatment × feed matrix interaction (P = 0.079, Table 3) in which the combination 
of CRINA and VevoVitall was more effective at reducing the amount of quantifiable 
RNA in FEED relative to no feed additive treatment or feed additives included indi-
vidually, and was no different than untreated or treatment with CRINA or VevoVitall 
individually in the SDPP matrix. There was no treatment × day interaction (P = 0.234). 
All main effects were highly significant, including treatment, day, and feed matrix (P ≤ 
0.003, Tables 2 and 3). Overall, the combination of CRINA and VevoVitall was most 
effective at reducing the quantity of genetic material (P < 0.001, Ct = 33.0; Table 3), 
regardless of feed matrix or day post-inoculation. All three feed samples treated with 
the COMBINATION did not have detectable PEDV RNA at d 42 post-laboratory 
inoculation, and two samples did not have detectable virus at d 21 post-laboratory 
inoculation. Cochrane et al. (2015) observed increased efficacy at reducing the amount 
of quantifiable RNA in complete swine diet and blood meal as the duration of the study 
progressed using a 2% essential oil blend (garlic oleoresin, turmeric oleoresin, capsicum 
oleoresin, rosemary extract, and wild oregano essential oils). The maximum efficacy was 
14 d post-inoculation and beyond in blood meal and beyond 21 d post-inoculation in 
the complete swine diet. In the current study, there was no difference in quantification 
of genetic material among the untreated control, CRINA, and VevoVitall treatments 
(P > 0.10; Ct = 31.8, 31.8, 31.9, respectively). Overall, a greater quantity of PEDV 
RNA was detected in SDPP relative to feed (P < 0.001, Ct = 29.3 ± 0.28 vs. 35.0 ± 
0.28, SDPP vs. feed, respectively). The PEDV Ct increased between d 0, 1, 3, 21, and 42 
post-laboratory inoculation (P < 0.001; 29.3, 30.7, 31.6, 33.9, and 35.2, respectively). 
There was no difference in Ct between d 3, 7, and 14 post-laboratory inoculation (P > 
0.05, 31.6, 32.1, and 32.2, respectively).
Infectivity
Upon completion of PCR testing, sixteen samples were strategically selected for 
assessment of virus infectivity via a bioassay at Iowa State University. The samples 
selected were d 0 negative control, 7 positive control, and 7 combination of CRINA 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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and VevoVitall samples. Each sample consisted of 3 supernatant aliquots that each 
were gavaged into a single pig within bioassay room. Six combinations were selected 
using swine feed and the combination of CRINA and VevoVitall (d 0, 1, 3, 7, 14, and 
21 post-laboratory inoculation) and an additional set of samples was selected using 
the combination of CRINA and VevoVitall 7 d after inoculation in SDPP. Positive 
control samples included untreated FEED and SDPP samples at d 0, 3, and 21 post-
laboratory inoculation as well as d 1 FEED positive control for a total of 7 total positive 
control bioassay rooms. The d 0 and d 1 FEED positive control samples were from the 
current study, however the other 5 positive control samples were in conjunction with 
additional research from our laboratory using identical procedures in which bioassay 
controls were shared across projects (Ct = 29.4, 34.1, 31.6, 37.3, 37.8; d 0 SDPP, d 3 
FEED, d 3 SDPP, d 21 FEED, d 21 SDPP, respectively). 
No PEDV RNA was detected in fecal swabs prior to initiation of the bioassay, and 
negative control pigs remained negative for PEDV genetic material for the full length 
of the bioassay as assessed by fecal swabs and cecal content collected at necropsy (Table 
4). Genetic material was detected in all positive control FEED pigs beginning at 2 dpi, 
and viral shedding was observed for the duration of the bioassay. All d 0 post-laboratory 
inoculation SDPP positive control pigs were shedding PEDV RNA throughout the 
bioassay, and cecal contents were positive for PEDV RNA at necropsy. No d 1 FEED 
positive control pigs had detectable RNA in fecal swabs or cecal contents in the second 
bioassay. All three d 3 post-laboratory inoculation SDPP positive control pigs began 
shedding virus at 2 dpi, whereas the d 3 post-laboratory inoculation FEED positive 
controls had no detectable RNA in fecal swabs throughout the bioassay or cecal content 
at necropsy. No d 21 post-laboratory inoculation positive control pigs had detectable 
virus in fecal swabs or cecal contents. Thus, pigs became infected with PEDV with 
both FEED and SDPP at d 0 post-laboratory inoculation, as well as d 3 post-laboratory 
inoculation in SDPP. 
The d 0 FEED combination of CRINA and VevoVitall pigs (3/3) were shedding PEDV 
RNA as detected by fecal swabs beginning on 2 dpi and remained infected through 
necropsy at 7 dpi. Virus shedding was observed in fecal swabs in one d 7 post-bioassay 
inoculation SDPP COMBINATION pig 2 dpi, and all three pigs were shedding 
virus at 6 dpi and had virus detectable in cecal contents at necropsy. None of the 
COMBINATION treated FEED had detectable RNA in fecal swabs or cecal contents 
with the exception of d 0 post-laboratory inoculation samples.
In summary, the combination of CRINA and VevoVitall enhanced degradation 
of PEDV RNA in swine feed, but had no impact on RNA degradation in SDPP. 
Furthermore, both untreated feed and feed treated with the combination of CRINA 
and VevoVitall resulted in PEDV infection at d 0 post-laboratory inoculation; however, 
neither set of samples were infective at d 1 post-laboratory inoculation.
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Table 1. Diet composition (as-fed basis)1
Item Swine gestation diet
Ingredient, %
Corn 80.40
Soybean meal, 46.5% CP 15.60




Trace mineral premix1 0.15











1 Each kilogram contains 26.4 g Mn, 110 g Fe, 110 g Zn, 11 g Cu, 198 mg I, and 198 mg Se.
2 Each kilogram contains 110,000 mg choline, 44 mg biotin, 330 mg folic acid, 990 mg pyridoxine.
3 Each kilogram contains 4,400,000 IU vitamin A, 660,000 IU vitamin D3, 17,600 IU vitamin E, 1,760 mg 
menadione, 3,300 mg riboflavin, 11,000 mg pantothenic acid, 19,800 mg niacin, 15.4 mg vitamin B12.
4 HiPhos 2700, DSM Nutritional Products, Parsippany, NJ.
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Table 2. Interactive means of VevoVitall and/or CRINA, matrix, and day, matrix by day 
interaction, and main effect of day on PEDV detection as determined by qRT-PCR1 
qRT-PCR Ct, Day post-inoculation
Item 0 1 3 7 14 21 42
Matrix × treatment × day2
FEED
No treatment 29.4 32.5 31.9 35.2 35.8 37.2 39.3(2/3)
CRINA 30.0 32.8 33.3 34.1 35.5 37.7 38.3
VevoVitall 29.8 31.7 33.5 33.4 35.6 38.0 40.4(2/3)
CRINA + VevoVitall 30.2 32.4 33.6 36.0 35.5 42.6(1/3) 45.0(0/3)
SDPP
No treatment 28.7 29.5 29.7 29.1 28.9 28.3 29.4
CRINA 28.4 29.3 29.3 29.1 28.2 30.3 29.4
VevoVitall 28.8 28.6 30.5 28.8 29.0 28.5 30.2
CRINA + VevoVitall 29.1 29.1 31.1 30.7 29.2 28.3 29.7
Matrix × day3
FEED 29.8e,f 32.3d 33.1d 34.7c 35.6c 38.9b 40.7a
SDPP 28.8f 29.1e,f 30.2e 29.4e,f 28.8f 28.9f 29.7e,f
Day4 29.3e 30.7d 31.6c 32.1c 32.2c 33.9b 35.2a
1 An initial tissue culture (2.5 mL diluted virus inoculum, 105 TCID50/mL) was inoculated into 22.5 grams of gestation 
diet (FEED) or spray-dried porcine plasma (SDPP) treated with 200 ppm CRINA, 5,000 ppm VevoVitall, combination of 
CRINA and VevoVitall (COMBINATION) (DSM Nutritional Products, Parsippany, NJ), or no feed additive treatment. 
Values are represented by mean quantified PEDV RNA cycle threshold (Ct) value as determined by qRT-PCR.  
(X/X) Superscripts denote number of samples with cycle threshold for PEDV RNA below detectable limit of Ct = 45. A 
value of 45.0 was used for assumed for samples with non-detectable RNA for analysis. 
2 Matrix × treatment × day interaction, n = 3 for each value. SEM = 0.90 cycle threshold, P = 0.082.
3 Matrix × day interaction, n = 12 for each value. SEM = 0.50 cycle threshold, P < 0.001.
4 Main effect of day, n = 24 for each value. SEM = 0.38 cycle threshold, P < 0.001.
abcdef Means within interaction or effect lacking a common superscript differ (P < 0.05).
Table 3. Interactive means of feed matrix and treatment, and main effect of treatment on 
PEDV detection using qRT-PCR1,2
Item Control CRINA VevoVitall
CRINA + 
VevoVitall SEM P =
Matrix × treatment
FEED3 34.5b 34.5b 34.6b 36.5a 0.37 0.079
SDPP4 29.1c 29.1c 29.2c 29.6c
Treatment 31.8b 31.8b 31.9b 33.0a 0.28 0.003
1 An initial tissue culture (2.5 mL diluted virus inoculum, 105 TCID50/mL) was inoculated into 22.5 grams of ges-
tation diet (FEED) or spray-dried porcine plasma (SDPP) treated with 200 ppm CRINA, 5,000 ppm VevoVitall, 
combination of CRINA and VevoVitall (COMBINATION) (DSM Nutritional Products, Parsippany, NJ), or 
no feed additive treatment. A total of 168 samples were used for the analysis with each treatment represented by a 
mean of n = 21 for the matrix × treatment interaction, and n = 42 for the main effect of treatment.
2 Cycle threshold required to detect genetic material. A higher Ct value is indicative of less genetic material present.
3 Swine gestation diet.
4 Spray-dried porcine plasma (APC Functional Proteins, Ankeny, IA).
a,b,c Means within interaction or effect lacking common superscript differ (P < 0.05).
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Table 4. Effects of VevoVitall and/or CRINA as potential porcine epidemic diarrhea 





Item -2 dpi 2 dpi 4 dpi 6 dpi 7 dpi
FEED
No treatment
d 0 no virus - - - - - - - - - - - - - - -
d 0 - - - + + + + + + + + + + + +
d 1 - - - - - - - - - - - - - - - 
d 3 - - - - - - - - - - - - - - -
d 21 - - - - - - - - - - - - - - - 
CRINA + VevoVitall
d 0 - - - + + + + + + + + + + + +
d 1 - - - - - - - - - - - - - - -
d 3 - - - - - - - - - - - - - - - 
d 7 - - - - - - - - - - - - - - - 
d 14 - - - - - - - - - - - - - - - 
d 21 - - - - - - - - - - - - - - - 
SDPP
No treatment
d 0 no virus - - -  - - - - - - - - - - - -
d 0 - - - + + + + + + + + + + + +
d 3 - - - + + + + + + + + + + + +
d 21 - - - - - - - - - - - - - - - 
CRINA + VevoVitall
d 7 - - - + - - + + - + + + + + +
1An initial tissue culture 2.5 mL diluted virus inoculum, 105 TCID50/mL) was inoculated into 22.5 grams of gesta-
tion diet (FEED) or spray-dried porcine plasma (SDPP) treated with 200 ppm CRINA, 5,000 ppm VevoVitall, 
combination of CRINA and VevoVitall (COMBINATION) (DSM Nutritional Products, Parsippany, NJ), or no 
feed additive treatment. The supernatant from each sample was then collected for pig bioassay on the appropriate 
day post-laboratory inoculation and preserved until initiation of the bioassay. The supernatant was administered 
one time via oral gavage on d 0 to each of three pigs per treatment (10 mL per pig). Pigs were initially 10 d old 
initial BW = 7.9 lb.
2 Day post-bioassay inoculation.
